VRN-16

N/A

Report date: 2025/09/03 17:58:19

NME

Base Information

Drug NameVRN-16

Drug Alias NameVRN16

ClassificationSmall molecules

Mechanisms of ActionMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase inhibitors

TargetsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVoronoi Inc

China Registration ClassN/A

Active CompaniesVoronoi Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A